ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
Chemico-Biological Interactions
Volume 164, Issue 3, 15 December 2006, Pages 174-180
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected
Article
Purchase PDF (551 K)

 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
View Record in Scopus
 
doi:10.1016/j.cbi.2006.09.011    How to Cite or Link Using DOI (Opens New Window)
Copyright © 2006 Elsevier Ireland Ltd All rights reserved.

Suppressive effect of Withania somnifera root powder on experimental gouty arthritis: An in vivo and in vitro study

Mahaboobkhan Rasoola, Corresponding Author Contact Information, E-mail The Corresponding Author and Palaninathan Varalakshmib

aFaculty of Biosciences, School of Bioengineering and Biosciences, Vellore Institute of Technology (Deemed University), Vellore 632014, Tamil Nadu, India bDepartment of Medical Biochemistry, Dr. ALMPGIBMS, University of Madras, Taramani Campus, Chennai 113, Tamil Nadu, India

Received 31 March 2006; 
revised 22 September 2006; 
accepted 26 September 2006. 
Available online 7 November 2006.

Purchase the full-text article



References and further reading may be available for this article. To view references and further reading you must purchase this article.

Abstract

The effect of Withania somnifera L. Dunal root powder on paw volume and serum lysosomal enzyme activities was investigated in monosodium urate crystal-induced rats. The levels of β-glucuronidase and lactate dehydrogenase were also measured in monosodium urate crystal incubated polymorphonuclear leucocytes (PMNL). A significant increase in the level of paw volume and serum lysosomal enzymes was observed in monosodium urate crystal-induced rats. The increased β-glucuronidase and lactate dehydrogenase level were observed in untreated monosodium urate crystal incubated polymorphonuclear leucocytes. On treatment with the W. somnifera root powder (500/1000 mg/kg body weight), the above changes were reverted back to near normal levels. W. somnifera also showed potent analgesic and antipyretic effect with the absence of gastric damage at different dose levels in experimental rats. For comparison purpose, non-steroidal anti-inflammatory drug (NSAID) indomethacin was used as a standard. These results provide evidence for the suppressive effect of W. somnifera root powder by retarding amplification and propagation of the inflammatory response without causing any gastric damage.

Keywords: Withania somnifera; Indomethacin; Gouty arthritis

Article Outline

1. Introduction
2. Materials and methods
2.1. Drug
2.2. Synthesis of monosodium urate crystals
2.3. Animals
2.4. Monosodium urate crystal-induced inflammation in rats
2.4.1. Assessment of inflammation
2.5. In vitro studies (monosodium urate crystal–PMNL cell interaction)
2.6. Test of the analgesic activity of W. somnifera
2.7. Test of the antipyretic activity of W. somnifera
2.8. Test of the ulcerogenic activity of W. somnifera
2.9. Statistical analysis
3. Results
3.1. Effect of W. somnifera root powder and indomethacin on in vivo studies
3.2. Effect of W. somnifera root powder and indomethacin on in vitro studies
3.3. Analgesic activity of W. somnifera root powder
3.4. Antipyretic effect of W. somnifera root powder
3.5. Ulcerogenic effect of W. somnifera root powder
4. Discussion
References






Chemico-Biological Interactions
Volume 164, Issue 3, 15 December 2006, Pages 174-180
 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Information for Advertisers  |  Terms & Conditions  |  Privacy Policy
Copyright © 2008 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.